0QF Fundamental Analysis - MODERNA INC

Fundamental Rating

0QF gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 82 industry peers in the Biotechnology industry. 0QF scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. 0QF is quite expensive at the moment. It does show a decent growth rate.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year 0QF has reported negative net income.

0QF had a negative operating cash flow in the past year.

In multiple years 0QF reported negative net income over the last 5 years.

The reported operating cash flow has been mixed in the past 5 years: 0QF reported negative operating cash flow in multiple years.

1.2 Ratios

0QF has a Return On Assets (-25.68%) which is in line with its industry peers.

The Return On Equity of 0QF (-33.40%) is better than 61.73% of its industry peers.

		Industry Rank	Sector Rank
ROA	-25.68%
ROE	-33.4%
ROIC	N/A

ROA(3y)-6.14%

ROA(5y)4.17%

ROE(3y)-7.66%

ROE(5y)6.83%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

0QF has a Gross Margin of 63.49%. This is comparable to the rest of the industry: 0QF outperforms 59.26% of its industry peers.

In the last couple of years the Gross Margin of 0QF has declined.

0QF does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	63.49%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-6.55%

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

0QF does not have a ROIC to compare to the WACC, probably because it is not profitable.

Compared to 1 year ago, 0QF has more shares outstanding

Compared to 5 years ago, 0QF has more shares outstanding

The debt/assets ratio for 0QF has been reduced compared to a year ago.

2.2 Solvency

0QF has an Altman-Z score of 2.86. This is not the best score and indicates that 0QF is in the grey zone with still only limited risk for bankruptcy at the moment.

0QF's Altman-Z score of 2.86 is fine compared to the rest of the industry. 0QF outperforms 71.60% of its industry peers.

0QF has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.

0QF has a better Debt to Equity ratio (0.00) than 87.65% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Altman-Z	2.86

ROIC/WACCN/A

WACC8.66%

2.3 Liquidity

0QF has a Current Ratio of 3.93. This indicates that 0QF is financially healthy and has no problem in meeting its short term obligations.

0QF's Current ratio of 3.93 is fine compared to the rest of the industry. 0QF outperforms 70.37% of its industry peers.

A Quick Ratio of 3.73 indicates that 0QF has no problem at all paying its short term obligations.

0QF has a better Quick ratio (3.73) than 70.37% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	3.93
Quick Ratio	3.73

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The earnings per share for 0QF have decreased strongly by -38.66% in the last year.

0QF shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -56.07%.

Measured over the past years, 0QF shows a very strong growth in Revenue. The Revenue has been growing by 122.01% on average per year.

EPS 1Y (TTM)-38.66%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-1800%

Revenue 1Y (TTM)-56.07%

Revenue growth 3Y-44.04%

Revenue growth 5Y122.01%

Sales Q2Q%-45.44%

3.2 Future

Based on estimates for the next years, 0QF will show a quite strong growth in Earnings Per Share. The EPS will grow by 16.53% on average per year.

The Revenue is expected to grow by 11.90% on average over the next years. This is quite good.

EPS Next Y-7.31%

EPS Next 2Y7.12%

EPS Next 3Y12.73%

EPS Next 5Y16.53%

Revenue Next Year-41%

Revenue Next 2Y-19.3%

Revenue Next 3Y-7.47%

Revenue Next 5Y11.9%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

0QF reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for 0QF. No positive earnings are expected for the next year.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as 0QF's earnings are expected to grow with 12.73% in the coming years.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y7.12%

EPS Next 3Y12.73%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for 0QF!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

MODERNA INC

FRA:0QF (12/5/2025, 7:00:00 PM)

23.505

+1.47 (+6.67%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences

GICS IndustryBiotechnology

Earnings (Last)11-06 2025-11-06/bmo

Earnings (Next)02-12 2026-02-12/amc

Inst Owners71.57%

Inst Owner ChangeN/A

Ins Owners2.54%

Ins Owner ChangeN/A

Market Cap9.18B

Revenue(TTM)2.23B

Net Income(TTM)-3.12B

Analysts55.86

Price Target32.91 (40.01%)

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)2

Avg EPS beat(2)52.94%

Min EPS beat(2)29.6%

Max EPS beat(2)76.27%

EPS beat(4)3

Avg EPS beat(4)30.21%

Min EPS beat(4)-6.26%

Max EPS beat(4)76.27%

EPS beat(8)7

Avg EPS beat(8)49.68%

EPS beat(12)9

Avg EPS beat(12)9.25%

EPS beat(16)12

Avg EPS beat(16)10.78%

Revenue beat(2)2

Avg Revenue beat(2)17.81%

Min Revenue beat(2)12.36%

Max Revenue beat(2)23.26%

Revenue beat(4)3

Avg Revenue beat(4)8.94%

Min Revenue beat(4)-0.3%

Max Revenue beat(4)23.26%

Revenue beat(8)7

Avg Revenue beat(8)29.87%

Revenue beat(12)10

Avg Revenue beat(12)27.21%

Revenue beat(16)13

Avg Revenue beat(16)22.97%

PT rev (1m)-11.22%

PT rev (3m)-12.73%

EPS NQ rev (1m)6.25%

EPS NQ rev (3m)8.29%

EPS NY rev (1m)-0.25%

EPS NY rev (3m)0.19%

Revenue NQ rev (1m)-14.43%

Revenue NQ rev (3m)-11.79%

Revenue NY rev (1m)0.21%

Revenue NY rev (3m)-1.53%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	4.8
P/FCF	N/A
P/OCF	N/A
P/B	1.15
P/tB	1.16
EV/EBITDA	N/A

EPS(TTM)-6.92

EYN/A

EPS(NY)-6.78

Fwd EYN/A

FCF(TTM)-5.84

FCFYN/A

OCF(TTM)-4.34

OCFYN/A

SpS4.9

BVpS20.47

TBVpS20.25

PEG (NY)N/A

PEG (5Y)N/A

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	-25.68%
ROE	-33.4%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	63.49%
FCFM	N/A

ROA(3y)-6.14%

ROA(5y)4.17%

ROE(3y)-7.66%

ROE(5y)6.83%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-6.55%

GM growth 5YN/A

F-Score2

Asset Turnover0.18

Health

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	329.33%
Cap/Sales	30.69%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	3.93
Quick Ratio	3.73
Altman-Z	2.86

F-Score2

WACC8.66%

ROIC/WACCN/A

Cap/Depr(3y)261.63%

Cap/Depr(5y)224.68%

Cap/Sales(3y)14.96%

Cap/Sales(5y)10.95%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-38.66%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-1800%

EPS Next Y-7.31%

EPS Next 2Y7.12%

EPS Next 3Y12.73%

EPS Next 5Y16.53%

Revenue 1Y (TTM)-56.07%

Revenue growth 3Y-44.04%

Revenue growth 5Y122.01%

Sales Q2Q%-45.44%

Revenue Next Year-41%

Revenue Next 2Y-19.3%

Revenue Next 3Y-7.47%

Revenue Next 5Y11.9%

EBIT growth 1Y-46.28%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year-0.33%

EBIT Next 3Y14.92%

EBIT Next 5Y17.94%

FCF growth 1Y-0.23%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y4.81%

OCF growth 3YN/A

OCF growth 5YN/A

MODERNA INC / 0QF.DE FAQ

Can you provide the ChartMill fundamental rating for MODERNA INC?

ChartMill assigns a fundamental rating of 3 / 10 to 0QF.DE.

What is the valuation status for 0QF stock?

ChartMill assigns a valuation rating of 0 / 10 to MODERNA INC (0QF.DE). This can be considered as Overvalued.

What is the profitability of 0QF stock?

MODERNA INC (0QF.DE) has a profitability rating of 2 / 10.

What is the expected EPS growth for MODERNA INC (0QF.DE) stock?

The Earnings per Share (EPS) of MODERNA INC (0QF.DE) is expected to decline by -7.31% in the next year.

MODERNA INC (0QF.DE) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

MODERNA INC / 0QF.DE FAQ

Can you provide the ChartMill fundamental rating for MODERNA INC?

What is the valuation status for 0QF stock?

What is the profitability of 0QF stock?

What is the expected EPS growth for MODERNA INC (0QF.DE) stock?